• N1-Methylpseudouridine: Translation Meets Metabolism

  2026-08-13

  A thought-leadership guide to N1-Methylpseudouridine, connecting mRNA translation enhancement and reduced immunogenicity with the metabolic control revealed by the TCAIM–OGDH mitochondrial study.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-13

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that connects m6A-dependent RNA regulation with iron availability and ferroptosis resistance in hepatocellular carcinoma. The work integrates cellular, organoid, mouse-model, mechanistic, and clinical evidence, providing a preclinical framework for sensitizing HCC to ferroptosis-oriented treatment.

• Cediranib (AZD2171): From VEGFR Potency to Translation

  2026-08-12

  A thought-leadership guide to using Cediranib (AZD2171) as a mechanistic research tool, linking VEGFR inhibition with time-resolved signaling, endothelial phenotypes, and more rigorous translational interpretation.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-12

  Isoproterenol sulfate dihydrate provides a mechanistically informative beta-adrenergic challenge for human sinoatrial node assembloids. This article explains how to use the compound to distinguish intrinsic pacemaker maturation from neural modulation in advanced cardiovascular research.

• Carvedilol Phosphate for IRI Research

  2026-08-11

  Carvedilol Phosphate gives researchers a soluble, high-purity non-selective beta blocker for dissecting GPCR signaling in cardiovascular and hepatic injury systems. This guide connects compound handling with hepatocyte–macrophage co-culture, ischemia–reperfusion injury model design, metabolite analysis, and practical troubleshooting.

• LDH Cytotoxicity Assay Kit: Practical Guide

  2026-08-10

  The LDH Cytotoxicity Assay Kit provides a non-radioactive method for cell cytotoxicity measurement by detecting LDH released into culture medium after loss of membrane integrity. It is appropriate for in vitro cytotoxicity and cell viability workflows, but it does not identify a specific cell-death pathway or replace mechanistic assays.

• Oleic Acid C18:1(9Z) in Lipid Signaling

  2026-08-09

  Oleic Acid, also designated C18:1(9Z), is a research lipid that links membrane composition with lipid metabolism, GPCR signaling, inflammation, and cell proliferation. In a hepatic ischemia-reperfusion model, oleic acid plus palmitic acid generated a lipid-loaded hepatocyte system used to test metabolic protection mechanisms.

• A1 Versus AMD3100 in Colorectal Cancer

  2026-08-08

  Khorramdelazad et al. evaluated A1, a fluorinated CXCR4 inhibitor, against AMD3100 across molecular simulation, CT-26 cell assays, and a syngeneic colorectal cancer model. A1 showed more favorable predicted CXCR4 binding and stronger effects on tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling, while the findings remain preclinical and require independent validation.

• Gamma-linolenic Acid: Applied Research Workflows

  2026-08-07

  Gamma-linolenic acid (GLA) supports differentiated workflows spanning leukotriene signaling, inflammatory-cell assays, lipid metabolism, and apoptosis screening. This guide translates its reported activity into practical dose-response, formulation, controls, troubleshooting, and carefully bounded immune-research applications.

• Indole-3-pyruvic Acid: Protocols and Innovations in Research

  2026-08-07

  Indole-3-pyruvic acid (IPA) stands out as a dual-domain probe for plant hormone biosynthesis and mammalian immune modulation. This article unpacks IPA’s robust application workflows, novel insights from cutting-edge cancer–microbiome studies, and actionable troubleshooting to elevate assay precision.

• L. plantarum P101 Alleviates Alcoholic Steatosis via AMPK Mo

  2026-08-06

  The reference study demonstrates that Lactiplantibacillus plantarum P101 (LP.P101) mitigates alcohol-induced hepatic lipid accumulation in mice by activating the AMPK signaling pathway. Mechanistic clarity is achieved through use of the AMPK inhibitor Dorsomorphin, linking probiotic effects to metabolic regulation with implications for gut-liver axis research.

• Verapamil ((±)-Verapamil): Advanced Workflows for Hypoxia Re

  2026-08-06

  Verapamil ((±)-Verapamil) from APExBIO delivers robust inhibition of TXNIP/NLRP3-mediated inflammation, enabling precise modeling of hypoxia-driven pathways in urothelial and cardiovascular systems. This guide translates new mechanistic insights into actionable protocols, troubleshooting tactics, and comparative research advantages across inflammation and multidrug resistance studies.

• AM 281: Precision CB1 Cannabinoid Receptor Antagonist Workfl

  2026-08-05

  Unlock advanced neuroprotection and cognitive research with AM 281, a highly selective CB1 cannabinoid receptor antagonist. This guide blends stepwise protocols, troubleshooting, and translational insight—based on new evidence for glutamate regulation and neuronal survival.

• UPF3A Expression Revealed as Ubiquitous Across Mouse Tissues

  2026-08-05

  This study overturns previous assumptions about UPF3A’s distribution, demonstrating that it is widely expressed across diverse mouse tissues, not just in male germlines. These findings refine the understanding of nonsense-mediated mRNA decay (NMD) regulation and suggest broader roles for UPF3A in tissue homeostasis.

• Recombinant Mouse SHH: Precision Modeling of Urogenital Morp

  2026-08-04

  Explore the cutting-edge use of Recombinant Mouse Sonic Hedgehog (SHH) protein in modeling urogenital development and congenital malformations. This in-depth analysis reveals new insights into SHH function, assay design, and practical decision-making for developmental biology researchers.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page